Helus Pharma, Inc. (HELP)
6.11
-0.67
(-9.88%)
USD |
NASDAQ |
Nov 20, 16:00
6.18
+0.07
(+1.15%)
After-Hours: 20:00
Helus Pharma Price to Book Value : 1.989 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 1.989 |
| November 19, 2026 | 2.207 |
| November 18, 2026 | 2.243 |
| November 17, 2026 | 2.344 |
| November 16, 2026 | 2.497 |
| November 13, 2026 | 2.887 |
| November 12, 2026 | 2.884 |
| November 11, 2026 | 3.056 |
| November 10, 2026 | 2.952 |
| November 09, 2026 | 3.05 |
| November 06, 2026 | 2.917 |
| November 05, 2026 | 2.731 |
| November 04, 2026 | 2.825 |
| November 03, 2026 | 2.939 |
| November 02, 2026 | 2.864 |
| October 30, 2026 | 3.449 |
| October 29, 2026 | 3.486 |
| October 28, 2026 | 3.551 |
| October 27, 2026 | 3.424 |
| October 26, 2026 | 3.372 |
| October 23, 2026 | 3.317 |
| October 22, 2026 | 3.418 |
| October 21, 2026 | 3.509 |
| October 20, 2026 | 3.561 |
| October 19, 2026 | 3.480 |
| Date | Value |
|---|---|
| October 16, 2026 | 3.434 |
| October 15, 2026 | 3.597 |
| October 14, 2026 | 3.379 |
| October 13, 2026 | 3.418 |
| October 12, 2026 | 3.590 |
| October 09, 2026 | 3.841 |
| October 08, 2026 | 3.490 |
| October 07, 2026 | 3.421 |
| October 06, 2026 | 3.502 |
| October 05, 2026 | 3.717 |
| October 02, 2026 | 3.808 |
| October 01, 2026 | 3.877 |
| September 30, 2026 | 4.000 |
| September 29, 2026 | 3.252 |
| September 28, 2026 | 3.224 |
| September 25, 2026 | 3.229 |
| September 24, 2026 | 3.224 |
| September 23, 2026 | 3.334 |
| September 22, 2026 | 3.510 |
| September 21, 2026 | 3.498 |
| September 18, 2026 | 3.167 |
| September 17, 2026 | 3.590 |
| September 16, 2026 | 3.449 |
| September 15, 2026 | 3.359 |
| September 14, 2026 | 3.485 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| NervGen Pharma Corp. | 6.439 |
| Milestone Pharmaceuticals, Inc. | -- |
| Appili Therapeutics, Inc. | -- |
| Clearmind Medicine, Inc. | 0.0545 |
| GH Research Plc | 3.449 |
Price to Book Value Related Metrics
| PEG Ratio | -0.1488 |
| Price | 6.11 |
| Earnings Yield | -69.77% |
| Market Cap | 486.05M |
| PEGY Ratio | -0.1488 |